Practice patterns among penile cancer surgeons performing dynamic sentinel lymph node biopsy and radical inguinal lymph node dissection in men with penile cancer: A eUROGEN survey
AuthorsFankhauser, Christian D
Ayres, B. E.
Sangar, Vijay K
Parnham, Arie S
AffiliationDepartment of Urology, The Christie NHS Foundation Trusts, Manchester
MetadataShow full item record
AbstractDynamic sentinel lymph node biopsy (DSNB) and radical inguinal lymph node dissection (ILND) are important in the management of penile cancer patients, but high-level evidence for preoperative, perioperative, and postoperative management remains scarce. According to an online survey of 35 surgeons from ten European countries, 57% perform >10 ILND procedures per year and 86% offer DSNB. Furthermore, management differs substantially for dye injection site, use of lymphoscintigraphy, preferred incision sites, techniques for lymphatic control, duration of empiric antibiotic therapy, perioperative thromboprophylaxis, time points for drain removal, and definition of the ILND dissection floor. Consensus was observed for the use of perioperative antibiotics (although not duration and type) and the borders for ILND template definitions. We conclude that there is significant variation in patient management among eUROGEN penile cancer surgeons. This heterogeneity may confound multicentre studies; therefore, a consensus to standardise inguinal node management in penile cancer across European penile cancer centres is warranted. Patient summary: Our survey reveals that preferences and surgical techniques for inguinal lymph node sampling and removal varies significantly between European penile cancer surgeons. Consensus is needed to standardise the management approach for penile cancer.
CitationFankhauser CD, Ayres BE, Issa A, Albersen M, Watkin N, Muneer A, et al. Practice Patterns Among Penile Cancer Surgeons Performing Dynamic Sentinel Lymph Node Biopsy and Radical Inguinal Lymph Node Dissection in Men with Penile Cancer: A eUROGEN Survey. European Urology Open Science. 2021 Feb;24:39–42.
JournalEuropean Urology Open Science
- Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation.
- Authors: de Vries HM, Lee HJ, Lam W, Djajadiningrat RS, Ottenhof SR, Roussel E, Kroon BK, de Jong IJ, Oliveira P, Alnajjar HM, Albersen M, Muneer A, Sangar V, Parnham A, Ayres B, Watkin N, Horenblas S, Stuiver MM, Brouwer OR
- Issue date: 2022 Jul
- Management of the lymph nodes in penile cancer.
- Authors: Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H
- Issue date: 2010 Aug
- Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging/therapy for penile cancer: A survey study.
- Authors: Marilin N, Master VA, Pettaway CA, Spiess PE
- Issue date: 2021 Jul
- Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes.
- Authors: Naumann CM, van der Horst S, van der Horst C, Kähler KC, Seeger M, Osmonov D, Lützen U, Jünemann KP, Franz Hamann M
- Issue date: 2015 Sep
- [Initial Experiences of Dynamic Sentinel Lymph Node Biopsy (DSNB) in Patients with Penile Cancer].
- Authors: Abe N, Hori JI, Kobayashi S, Kikuchi D, Tateoka J, Watanabe M, Wada N, Tamaki G, Kita M, Matsuya T, Ishida-Yamamoto A, Kakizaki H
- Issue date: 2020 Jul